To faithfully recapitulate the development of human locally advanced rectal cancer (LARC), we utilized a genetically engineered mouse model of colorectal cancer, which harbors a Doxycycline (Dox)-inducible oncogenic Kras allele and conditional null alleles of Apc and Trp53 (iKAP) [25]. The gene discussed is KRAS; the disease is colorectal cancer.